| 000 | 01366 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514235234.0 | ||
| 264 | 0 | _c20070216 | |
| 008 | 200702s 0 0 chi d | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhao, Xiao-Dong | |
| 245 | 0 | 0 |
_a[Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma]. _h[electronic resource] |
| 260 |
_bAi zheng = Aizheng = Chinese journal of cancer _cAug 2005 |
||
| 300 |
_a1002-5 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCystadenocarcinoma, Serous _xdrug therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aPostoperative Period |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aZhang, Qiao | |
| 700 | 1 | _aZhang, Yi | |
| 773 | 0 |
_tAi zheng = Aizheng = Chinese journal of cancer _gvol. 24 _gno. 8 _gp. 1002-5 |
|
| 999 |
_c15725218 _d15725218 |
||